Skip to main content

Table 2 Detection rates for the GynTect assay in different age groups. Especially the NILM group is very imbalanced between the age groups

From: Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages

<35y

CxCa (n = 2)

CIN3 (n = 22)

CIN2 (n = 5)

CIN1 (n = 3)

NILM (n = 38)

# tested samples

2

22

5

3

38

# GynTect positive

2

12

2

0

0

# GynTect negative

0

9

3

3

37

# GynTect invalid

0

1

0

0

1

# valid samples

2

21

5

3

37

detection rate [%]

100.0%

57.1%

40.0%

0.0%

0.0%

≥ 35y

CxCa (n = 3)

CIN3 (n = 28)

CIN2 (n = 14)

CIN1 (n = 2)

NILM (n = 163)

# tested samples

3

28

14

2

163

# GynTect positive

3

18

6

1

3

# GynTect negative

0

10

7

1

159

# GynTect invalid

0

0

1

0

1

# valid samples

3

28

13

2

162

detection rate [%]

100.0%

64.3%

46.2%

50.0%

1.9%